Topic

Articles

A look at how real world data and real world evidence are shaping more decentralized trial designs for potential COVID-19 treatments. 

Innovative Clinical Trial Designs Emerge from Pandemic

Study offers clues for installing rapid R&D tactics post-pandemic.

Applying Pre-Pandemic Benchmarks to Assess Future Speed Strategies

Rasmus Hogreffe, former Head of Virtual Trials at LEO Innovation Lab, and Morten Kirkegaard, Head of Clinical Operations and Co-founder at REDO-neurosystems, discuss their experiences with decentralized trials.

Decentralized Trials: Opening New Opportunities in Clinical Research

A look into the future based off what we've learned about trials during the pandemic.

Trial Innovation Beyond the COVID-19 Pandemic

A look at the future of clinical trial laboratory testing amid the emerging use of new devices at the point of care.

Integration of Point-of-Care Devices in Clinical Trials

Competency-based and other creative approaches are needed to address the battle for talent in the clinical research workforce. 

Combating the ‘Talent  Wars’ in Biopharma

Dr. Michelle Longmire, Chief Executive Officer and founder of Medable, sits down with Moe Alsumidaie to discuss how the decentralized model will transform how trials are executed for years to come. 

Insights on Decentralized Trial Execution

Findings from the most recent Biopharma Confidence Index show that the pandemic has substantially influenced biopharma executives’ expectations in key areas like artificial intelligence/machine learning and real-world evidence. 

C-Suite Survey Underscores Digital Technology’s Growing Role in Clinical Trials

Beyond technology, awareness, and access—cultural competence is key.